Noun G, Reboul M, Abastado J P, Jaulin C, Kourilsky P, Pla M
Mouse Immunogenetics, Unit 93 INSERM, Saint-Louis Hospital, Paris, France.
J Immunol. 1996 Sep 15;157(6):2455-61.
As a part of our continuing effort to study the antigenic structure of class I molecules, we have undertaken two types of studies. First, we have studied the capacity of five different Kd-reactive mAbs to recognize a panel of 25 site-directed mutants of the H-2Kd molecule. Both the gain and the decrease in Ab binding resulted from a single amino acid substitution at different positions. All mutations that increase the binding of the tested mAbs are located on the alpha-helices, indicating that the replacement of an Ig-contacting surface residue with a charged or polar side chain by a short one generally favors Ab binding. Mutation of two alpha-helix-situated residues, 58 and 166, completely abolished the binding of one mAb (Tu191.7.1), indicating that these two residues contribute to the antigenic determinant defined by this mAb. The overwhelming majority of mutations that diminished Ab binding concerns residues buried within the Ag binding groove, suggesting the possibility of peptide contribution to serologic epitopes defined by alloreactive Abs. We have addressed this issue by comparison of the repertoire of peptides eluted from Kd molecules precipitated by different Kd-reactive mAbs. The results reveal that the two-dimensional profile obtained with one (F35.119.18) of the alloreactive mAbs is clearly different. The use of 21 single amino acid variants of a Kd-restricted 10-mer peptide allowed us to identify the residue of the bound peptide contributing to the epitope recognized by this mAb. Thus, we have shown that at least in some instances, changes induced in the MHC molecules by the binding of distinct peptides can be recognized as alterations in serologic determinants expressed on the class I molecules.
作为我们对I类分子抗原结构持续研究工作的一部分,我们开展了两类研究。首先,我们研究了五种不同的Kd反应性单克隆抗体识别一组25个H-2Kd分子定点突变体的能力。抗体结合的增加和减少均源于不同位置的单个氨基酸取代。所有增加测试单克隆抗体结合的突变都位于α螺旋上,这表明用短的带电荷或极性侧链取代与免疫球蛋白接触的表面残基通常有利于抗体结合。两个位于α螺旋的残基58和166发生突变,完全消除了一种单克隆抗体(Tu191.7.1)的结合,表明这两个残基构成了该单克隆抗体所定义的抗原决定簇。绝大多数减少抗体结合的突变涉及埋藏在抗原结合槽内的残基,这提示了肽对同种反应性抗体所定义的血清学表位有贡献的可能性。我们通过比较从不同Kd反应性单克隆抗体沉淀的Kd分子上洗脱的肽库来解决这个问题。结果显示,用一种同种反应性单克隆抗体(F35.119.18)获得的二维图谱明显不同。使用一种Kd限制性十肽的21个单氨基酸变体,使我们能够鉴定出结合肽中对该单克隆抗体所识别的表位有贡献的残基。因此,我们已经表明,至少在某些情况下,不同肽的结合在MHC分子中诱导的变化可被识别为I类分子上表达的血清学决定簇的改变。